| 臺大學術典藏 |
2020-02-06T05:21:52Z |
Clinical management and risk reduction in women with low-grade squamous intraepithelial lesion cytology: A population-based cohort study
|
Taiwan Cervical Cancer Control Task Force;WEN-FANG CHENG;Chen C.-A.;Chen H.-C.;You S.-L.;Chiang C.-J.;Hsu H.-C.;Chen Y.-Y.;Tai Y.-J.; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen H.-C.; Chen C.-A.; WEN-FANG CHENG; Taiwan Cervical Cancer Control Task Force; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen H.-C.; Chen C.-A.; WEN-FANG CHENG; Taiwan Cervical Cancer Control Task Force |
| 臺大學術典藏 |
2020-02-06T05:21:51Z |
Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review
|
Lin M.-C.; Chen C.-A.; WEN-FANG CHENG; WEN-FANG CHENG;Chen C.-A.;Lin M.-C.;Chen Y.-L.;Tu Y.-A.; Tu Y.-A.; Chen Y.-L.; Lin M.-C.; Chen C.-A.; WEN-FANG CHENG; Tu Y.-A.; Chen Y.-L. |
| 臺大學術典藏 |
2020-02-06T05:21:51Z |
Health effects of a forest environment on natural killer cells in humans: An observational pilot study
|
Tsao T.-M.; Tsai M.-J.; Hwang J.-S.; WEN-FANG CHENG; Wu C.-F.; Chou C.-C.; Su T.-C.; Tsao T.-M.; Tsai M.-J.; Hwang J.-S.; WEN-FANG CHENG; Wu C.-F.; Chou C.-C.; Su T.-C.; Su T.-C.;Chou C.-C.;Wu C.-F.;WEN-FANG CHENG;Hwang J.-S.;Tsai M.-J.;Tsao T.-M. |
| 臺大學術典藏 |
2020-02-06T05:21:51Z |
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
|
WEN-FANG CHENG;Tang C.-H.;Hsieh S.-F.;You S.-L.;Chen Y.-Y.;Chiang C.-J.;Chen C.-A.; Chen C.-A.; Chiang C.-J.; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG; Chen C.-A.; Chiang C.-J.; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: A population-based cohort study
|
WEN-FANG CHENG;Chen C.-A.;You S.-L.;Chiang C.-J.;Hsu H.-C.;Chen Y.-Y.;Tai Y.-J.; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
|
WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Sun N.-Y.;Lin H.-W.;Chiang Y.-C.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Torsion of pedunculated subserous uterine leiomyoma: A rare complication of a common disease
|
WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Lai Y.-L.; Lai Y.-L.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Lai Y.-L.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Prognostic factors in epithelial ovarian cancer: A population-based study
|
WEN-FANG CHENG;Wu F.-L.L.;Shen L.-J.;Lai M.-S.;Huang C.-F.;Chang L.-C.; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; Wu F.-L.L.; WEN-FANG CHENG; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; Wu F.-L.L.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:49Z |
Factors predicting parametrial invasion in patients with early-stage cervical carcinomas
|
WEN-FANG CHENG; Chiang Y.-C.; Chen C.-A.; Chen Y.-L.; Tai Y.-J.; Hsu H.-C.; WEN-FANG CHENG; Chen C.-A.; Chiang Y.-C.; Chen Y.-L.; Tai Y.-J.; Hsu H.-C.; WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Chen Y.-L.;Tai Y.-J.;Hsu H.-C. |
| 臺大學術典藏 |
2020-02-06T05:21:49Z |
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study
|
Yen M.-S.;Hsiao S.-M.;Kan Y.-Y.;Kang C.-Y.;Huang C.-Y.;Chang Y.-Y.;Chen Y.-C.;Ke Y.-M.;Chiang A.-J.;WEN-FANG CHENG;Hsu K.-F.;Chen M.-Y.;Chen J.-R.;Fu H.-C.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S. |
| 臺大學術典藏 |
2020-02-06T05:21:49Z |
Vitamin D�Vbinding protein enhances epithelial ovarian cancer progression by regulating the insulin-like growth factor-1/akt pathway and Vitamin D receptor transcription
|
Chou C.-Y.;Shen W.-L.;Peng S.-L.;WEN-FANG CHENG;Wu Y.-H.;Huang Y.-F.; Huang Y.-F.; Wu Y.-H.; WEN-FANG CHENG; Peng S.-L.; Shen W.-L.; Chou C.-Y.; Huang Y.-F.; Wu Y.-H.; WEN-FANG CHENG; Peng S.-L.; Shen W.-L.; Chou C.-Y. |
| 臺大學術典藏 |
2020-02-06T05:21:48Z |
Cost-effectiveness analysis of human papillomavirus vaccination in adolescent girls in Taiwan
|
Lee C.;Van Kriekinge G.;Mukherjee P.;Hsieh J.-Y.;Huang L.-W.;You S.L.;Jiang J.-H.;WEN-FANG CHENG;Tang C.-H.; Tang C.-H.; WEN-FANG CHENG; Jiang J.-H.; You S.L.; Huang L.-W.; Hsieh J.-Y.; Mukherjee P.; Van Kriekinge G.; Lee C.; Tang C.-H.; WEN-FANG CHENG; Jiang J.-H.; You S.L.; Huang L.-W.; Hsieh J.-Y.; Mukherjee P.; Van Kriekinge G.; Lee C. |
| 臺大學術典藏 |
2020-02-06T05:21:48Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Lin H.-P.;Lu T.-P.;Chang M.-C.;Fu C.-F.;Lin H.-W.; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:48Z |
CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells
|
WEN-FANG CHENG;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chen Y.-L.;Sun N.-Y.;Chiang Y.-C.;Lin H.-W.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:47Z |
Bevacizumab dose affects the severity of adverse events in gynecologic malignancies
|
Hsu H.-C.; Tai Y.-J.; Chen Y.-L.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; Lee S.-P.; Hsu H.-C.; Tai Y.-J.; Chen Y.-L.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Chen Y.-L.;Tai Y.-J.;Hsu H.-C.;Lee S.-P.; Lee S.-P. |
| 臺大學術典藏 |
2020-02-06T05:21:46Z |
Prognostic factors of early stage epithelial ovarian carcinoma
|
WEN-FANG CHENG;Twu N.-F.;Hsu H.-C.;Wu H.-H.;Lau H.-Y.;Hsieh S.-F.; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; Hsu H.-C.; Twu N.-F.; WEN-FANG CHENG; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; Hsu H.-C.; Twu N.-F.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:46Z |
Clear cell carcinoma of the abdominal wall as a rare complication of general obstetric and gynecologic surgeries: 15 years of experience at a large academic institution
|
WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Kuo K.-T.;Hsu H.-C.;Lai Y.-L.; Lai Y.-L.; Hsu H.-C.; Kuo K.-T.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Lai Y.-L.; Hsu H.-C.; Kuo K.-T.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:46Z |
Developing a prognostic gene panel of epithelial ovarian cancer patients by a machine learning model
|
Chen C.-A.;WEN-FANG CHENG;Chiang Y.-C.;Hu Y.-H.;Lin H.-P.;Chang M.-C.;Chen C.-H.;Kuo K.-T.;Lu T.-P.; Lu T.-P.; Kuo K.-T.; Chen C.-H.; Chang M.-C.; Lin H.-P.; Hu Y.-H.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A.; Lu T.-P.; Kuo K.-T.; Chen C.-H.; Chang M.-C.; Lin H.-P.; Hu Y.-H.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A. |
| 臺大學術典藏 |
2020-02-06T05:21:45Z |
Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes
|
WEN-FANG CHENG;Chien C.-L.;Sun W.-Z.;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chiang Y.-C.;Lin H.-W.;Chen Y.-L.;Sun N.-Y.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:43Z |
Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center
|
Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Chiang Y.-C.; Hsu H.-C.; WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Chiang Y.-C.;Hsu H.-C.;Tai Y.-J.; Tai Y.-J.; Hsu H.-C.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-J. |
| 臺大學術典藏 |
2020-02-06T05:21:43Z |
mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment
|
WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Hung H.-C.;Yie J.-C.;Sun N.-Y.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:41Z |
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes
|
WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; Lai Y.-L.; Chien C.-L.; Lin H.-W.; Chen Y.-L.; WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG;Chen C.-A.;Sun W.-Z.;Lai Y.-L.;Chien C.-L.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Chien C.-L.; Lai Y.-L. |
| 臺大學術典藏 |
2019-09-09T00:55:36Z |
Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center
|
YING-CHENG CHIANG;Chen, Chi An;Hsu, Heng Cheng;Tai, Yi Jou;WEN-FANG CHENG;Chen, Yu Li; Chen, Yu Li; WEN-FANG CHENG; Tai, Yi Jou; Hsu, Heng Cheng; Chen, Chi An |
| 臺大學術典藏 |
2019-09-09T00:55:20Z |
mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment
|
Yie, Jr Chi; Sun, Nai Yun; WEI-ZEN SUN; Chen, Chi An;WEN-FANG CHENG;Lin, Han Wei;Hung, Hsueh Chih;Chen, Yu Li;Yie, Jr Chi;Sun, Nai Yun;WEI-ZEN SUN; Chen, Yu Li; Hung, Hsueh Chih; Lin, Han Wei; WEN-FANG CHENG; Chen, Chi An |
| 臺大學術典藏 |
2019-09-09T00:55:20Z |
Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes
|
Sun, Nai Yun;WEN-FANG CHENG;WEI-ZEN SUN;Chen, Chi An;Lin, Han Wei;CHUNG-LIANG CHIEN;Tai, Yi Jou;Chang, Chi Fang;YING-CHENG CHIANG;Chen, Yu Li; Chen, Yu Li; YING-CHENG CHIANG; Chang, Chi Fang; Tai, Yi Jou; CHUNG-LIANG CHIEN; Lin, Han Wei; Chen, Chi An; Sun, Nai Yun |
